AÅžI613 - NON-CLINICAL TOXICITY STUDIES ON VACCINES and TOXI
Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
---|---|---|---|---|---|---|
NON-CLINICAL TOXICITY STUDIES ON VACCINES and TOXI | AÅžI613 | 1st Semester | 2 | 0 | 2 | 8 |
Prequisites | None | |||||
Course language | Turkish | |||||
Course type | Elective | |||||
Mode of Delivery | Face-to-Face | |||||
Learning and teaching strategies | Lecture Discussion | |||||
Instructor (s) | Assoc Prof. Dr. Pınar Erkekoğlu Prof.Dr. A. Fliz Öner Assoc Prof. Dr. Emirhan Nemutlu | |||||
Course objective | The objective of this course is to give information to students on the non-clinical studies performed on vaccines, give knowledge on the ingredients present in vaccines and inform the students on the different toxicity tests performed for vaccines. | |||||
Learning outcomes |
| |||||
Course Content | The students will gain knowledge on the following at the end of this course: I. the toxicity of the ingredients in the vaccines II. all studies other than clinical studies performed on vaccines | |||||
References | 1. Casarett & Doull's Toxicology: The Basic Science of Poisons, Eighth Edition 2. The Vaccine Book Second edition 2016. (Barry R. Bloom and Paul-Henri Lambert, 2016). 3. Vaccine Excipient & Media Summary. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf 4. WHO Guidelines on Nonclinical Evaluation of Vaccines, WHO, Geneva, Switzerland (2003). 5. EMEA. (2010). Guideline on repeated dose toxicity, CPMP/SWP/1042/99 Rev 1 Corr* 6. WHO guidelines on nonclinical evaluation of vaccines. WHO Technical Report Series, No. 927, 2005. http://www.who.int/biologicals/publications/trs/areas/vaccines/nonclinical_evaluation/ANNEX%201Nonclinical.P31-63.pdf?ua=1 7. WHO Guidelines. Annex 2. Guidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccineshttp://www.who.int/biologicals/areas/vaccines/TRS_987_Annex2.pdf?ua=1 |
Course outline weekly
Weeks | Topics |
---|---|
Week 1 | A general overview on the toxic effects of vaccines. |
Week 2 | The possible toxic effects of preservatives in vaccines: Thimerosal and formaldehyde |
Week 3 | Toxic effects of adjuvants and other compounds in vaccines: Aluminum and antibiotics (streptomycin, amphotericin B, etc.) |
Week 4 | Toxic effects of adjuvants and other compounds in vaccines: monosodium glutamate, polysorbate 20, polysorbate 80, peanut oil, genetically modified organisms (GMOs) |
Week 5 | Toxic effects of adjuvants and other compounds in vaccines: Egg proteins, squalene, gelatin, sorbitol, residual MRC5 proteins |
Week 6 | The importance of non-clinical tests on vaccines and the points that should be notes while conducting these tests |
Week 7 | Acute (single dose) toxicity tests on vaccines |
Week 8 | chronic (repeated dose) toxicity tests on vaccines |
Week 9 | Reproductive and developmental toxicity tests on vaccines |
Week 10 | Local toxicity tests on vaccines |
Week 11 | Vaccines and immunotoxicity |
Week 12 | Vaccines and genotoxicity, carcinogenicity and teratogenicity tests |
Week 13 | Seminar, Discussion |
Week 14 | Seminar, Discussion |
Week 15 | Preparation for Final Exam |
Week 16 | Final exam |
Assesment methods
Course activities | Number | Percentage |
---|---|---|
Attendance | 14 | 10 |
Laboratory | 0 | 0 |
Application | 0 | 0 |
Field activities | 0 | 0 |
Specific practical training | 0 | 0 |
Assignments | 0 | 0 |
Presentation | 1 | 10 |
Project | 0 | 0 |
Seminar | 1 | 10 |
Midterms | 1 | 20 |
Final exam | 1 | 50 |
Total | 100 | |
Percentage of semester activities contributing grade succes | 1 | 50 |
Percentage of final exam contributing grade succes | 1 | 50 |
Total | 100 |
WORKLOAD AND ECTS CALCULATION
Activities | Number | Duration (hour) | Total Work Load |
---|---|---|---|
Course Duration (x14) | 14 | 2 | 28 |
Laboratory | 0 | 0 | 0 |
Application | 0 | 0 | 0 |
Specific practical training | 0 | 0 | 0 |
Field activities | 0 | 0 | 0 |
Study Hours Out of Class (Preliminary work, reinforcement, ect) | 10 | 10 | 100 |
Presentation / Seminar Preparation | 1 | 10 | 10 |
Project | 0 | 0 | 0 |
Homework assignment | 1 | 20 | 20 |
Midterms (Study duration) | 1 | 15 | 15 |
Final Exam (Study duration) | 1 | 40 | 40 |
Total Workload | 28 | 97 | 213 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
D.9. Key Learning Outcomes | Contrubition level* | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
1. Has knowledge of research methods and statistical methods used in the vaccinology and has knowledge about comparing existing studies and evaluating their limitations, accuracy, validity and reliability | X | ||||
2. Has knowledge on ethical principles with respect to all kinds of scientific and professional work in the area of vaccinology, and acts accordingly. | X | ||||
3. Using the knowledge and the skills he/she gained, detects existing vaccination problems in communities, produces recommendations by developing policies and strategies, and shares the information, takes part in a team work | X | ||||
4. Can gather information about the safety of vaccine, | X | ||||
5. Comprehends, assesses, and interprets interdisciplinary interaction in vaccinology. | X | ||||
6. Can design and apply an experimental setup in a laboratory environment and can analyze the obtained data. | X | ||||
7. Know the principles of good laboratory practice and good clinical practice. | X | ||||
8. Knows which type of study to conduct in acute conditions, providing required evidence for appropriate interventions and takes part in the process for effective and quick solutions | X | ||||
9. Evaluates the international developments in the vaccinology independently regarding conditions, | X | ||||
10. Contributes to health policy studies | X | ||||
11. Conducts scientific research, writes and presents scientific papers on vaccinology. | X | ||||
12. Evaluate quantitative and qualitative techniques in health economics and pharmacoeconomics | X |
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest